SI‑BONE Board Member Jeryl H. Hilleman Buys 10,957 Shares Amid Surge in Insider Buying – A Signal of Confidence?

Insider Activity at SI‑BONE Inc. – What the Latest Trade Means for Investors

A Quiet Buy Amidst a Volatile Season

On June 4, 2026, board member Jeryl H. Hilleman purchased 10,957 shares of SI‑BONE Inc. at the prevailing market price of $15.43, a transaction that raised his post‑transaction holding to 43,772 shares. The buy was executed at a time when the stock had already posted a strong weekly gain of 10.35 % and a month‑to‑date rally of over 33 %. Despite the company’s negative P/E ratio of –38.88 and a steep 17.8 % decline over the last year, Hilleman’s purchase signals confidence in the firm’s recovery trajectory, especially after the company’s recent lease renewal and the successful vote of shareholders on executive compensation.

Patterns in Board‑Member Trading

Hilleman’s trade is part of a broader pattern of activity by SI‑BONE’s leadership. Over the past two months, several directors—including Jeff Dunn, Mika Nishimura, and Thomas West—have acquired 10,957 shares in a series of buy trades. At the same time, executive sales have been sporadic, with CEO Laura Francis and CFO Anshul Maheshwari selling sizable blocks in late May and early February, respectively. The timing of these sales—often at higher price points—suggests a “mark‑up” strategy, while the recent purchases are generally at or near the market price, indicating an intent to support the share price rather than to realize gains.

Implications for Investors

1. Signal of Confidence Insider buying, particularly by a board member, is traditionally viewed as a positive signal. It implies that those with the most intimate knowledge of the company’s prospects believe the stock is undervalued. In SI‑BONE’s case, Hilleman’s buy coincides with a strong earnings run and a positive outlook on the company’s minimally invasive joint systems.

2. Liquidity and Volatility Considerations The company’s market cap of ~$673 million and a high share float suggest that even modest insider purchases can influence short‑term liquidity. However, the recent volatility—evidenced by a 52‑week low of $11.48—means that investors should remain cautious. A single large block trade may not move the market significantly but could signal a potential shift in sentiment.

3. Strategic Alignment with Shareholder Returns SI‑BONE’s recent annual meeting approved an advisory vote on executive compensation, hinting at a corporate governance environment that rewards long‑term shareholder value. Insider buying aligned with this governance framework reinforces the likelihood that the company is positioning itself for sustainable growth rather than short‑term gains.

4. Potential for Follow‑On Trading If the company’s fundamentals improve—particularly its operating margin and product pipeline—additional insider purchases may follow. Investors should monitor subsequent Form 4 filings for signs of continued buying by Hilleman or other directors, as this could precede a breakout.

Conclusion

Hilleman’s June 4 purchase, though modest in absolute terms, fits within a broader insider buying trend that offers a cautiously optimistic signal to investors. Coupled with SI‑BONE’s recent lease renewal, robust weekly gains, and a governance structure that aligns executive incentives with shareholder returns, the trade suggests that the company is positioning itself for a rebound. Investors should weigh this insider confidence against the company’s high debt levels, negative P/E, and recent price volatility, but the current insider activity does provide a compelling narrative that SI‑BONE’s management believes the stock is poised for a meaningful upside.